A critical advance in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital tumor suppressor protein is frequently disabled in various forms of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research